-
Urolithin A may act on obesity and metabolic dysfunction through multiple pathways
Urolithin A, a gut microbiota metabolite from ellagitannins, shows multi-target potential for obesity and metabolic dysfunction through thermogenesis activation, lipid metabolism regulation, and.
-
Combination therapy showed a temporary response in metastatic DDCS
Case report demonstrates promising response to pembrolizumab and pazopanib combination therapy in metastatic dedifferentiated chondrosarcoma, highlighting emerging systemic treatment options.
-
Maternal microbiota affects pregnancy outcomes and infant immune development
How maternal and infant gut microbiomes shape pregnancy outcomes, immune development, and long-term health during the critical first 1000 days of life.
-
Gut microbiome is linked to colorectal cancer development and management
Review of gut microbiome mechanisms in colorectal cancer carcinogenesis, examining pathogenic bacteria, protective functions, biomarker development, and therapeutic strategies.
